Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.

Saved in:
Bibliographic Details
Title: Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
Authors: Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Barocas DA; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Huang LC; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Zhao Z; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Koyama T; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Conwill R; Patient Advocacy Program, Office of Patient and Community Education, Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center, Nashville, Tennessee., Goodman M; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia., Hamilton AS; Department of Preventative Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California., Wu XC; Department of Epidemiology, Louisiana State University New Orleans School of Public Health, New Orleans, Louisiana., Paddock LE; Department of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey., Stroup AM; Department of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey., Cooperberg MR; Department of Urology, University of California San Francisco, San Francisco, California., Hashibe M; Department of Family and Preventative Medicine, University of Utah School of Medicine, Salt Lake City, Utah., O'Neil BB; Department of Urology, University of Utah Health, Salt Lake City, Utah., Kaplan SH; Department of Medicine, University of California Irvine, Irvine, California., Greenfield S; Department of Medicine, University of California Irvine, Irvine, California., Penson DF; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee., Hoffman KE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Source: Cancer [Cancer] 2021 Jun 01; Vol. 127 (11), pp. 1912-1925. Date of Electronic Publication: 2021 Feb 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0142
DOI:10.1002/cncr.33388